Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-10-03
2011-11-15
Chandra, Gyan (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S009400, C514S021400
Reexamination Certificate
active
08058227
ABSTRACT:
Disclosed are compositions and methods for the treatment of fibrosis. Also disclosed are methods of screening for agents that treat fibrosis.
REFERENCES:
patent: 7494976 (2009-02-01), Sessa
Tourkina et al., J.Biol. chem. 280:13879-13887, 2006.
Wells, 1990, Biochemistry 29:8509-8517.
Bowie et al., Science 247: 1306-1310, 1990.
Anderson RG. The caveolae membrane system. Annu Rev Biochem , 67:199-225, 1998.
Bellini A, Mattoli S. The role of the fibrocytes, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibrosis. Lab Invest, 2007.
Beon M, Harley RA, Wessels A, Silver RM, Ludwicka-Bradley A. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clin Exp Rheumatol, 22: 733-742, 2004.
Bernatchez P, Bauer P, Yu J, Prendergast J, He P, Sessa W. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc Natl Acad Sci U S A, 102:761-766, 2005.
Bogatkevich GS, Tourkina E, Silver RM, Ludwicka-Bradley A. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem , 276:45184-45192, 2001.
Bogatkevich GS, Tourkina E, Abrams CS, Harlley CA, Silver RM, Ludwicka-Bradley A. Contractile Activity and Smooth Muscle alpha-actin organization in thrombin-induced human lung myofibroblasts. Am. J. Physiol Lung CEll Mol Physiol, 85:L334-L343, 2003.
Bucci M, Gratton J-P, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesys and reduces inflammation. Nature Med, 6:1362-1367, 2000.
Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira de Souza A, Kitsis RN, Russell RG, Weiss LM. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 284:C457-474, 2003.
Couet J, Sargiacomo M, and Lisanti, MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272:30429-30438, 1997.
Cui J, Holgado-Magruda M, Su W, Tsuiki H, Wedegaertner P, Wong AJ. Identification of specific domain responsible for JNK2alpha2 autophosphorylation. J. Biol. Chem. 280:9913-9920, 2005.
Drab M, Vercade P, Elger M, Kasper M, Lohn M, Lauterbach B., Menne J., Lindschau C., Mende F., Luft F. C., Schedl A., Haller H., and Kurzchalia T. V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science, 293:2449-2452, 2001.
Finch WR, Rodnan GP, Buckingham RB, Prince RK, Winkelstein A. Bleomycin-induced scleroderma. J Rheumatol ,7:651-659, 1980.
Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer J, Sargiacomo M, Scherer PE, Engelman JA, Schlegel A, Parenti M. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci U S A, 95:10257-10262, 1998.
Gray AJ, Bishop JE, Reeves JT, Mecham RP, Laurent GJ. Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am J Respirator Cell Mol Biol, 12: 684-690, 1995.
Hong KM, Belperio JB, Keane MP, Burdick MD, Strieter RM. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferators activated receptor-gamma. J Biol Chem, 2007.
Hua H, Munk S, Whiteside CI. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal Physiol, 284:F303-312, 2003.
Kasper M, Reimann T, Hempe, U, Wenze KW, Bierhaus A, Schuh D, Dimmer V, Haroske G, Muller M. Loss of caveolin-1 expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem Cell Biol, 109:41-48, 1998.
Kim KK, Kudler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman NA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA, 103: 13180-13185, 2006.
Lisanti M, Scherer P, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu Y-H, Cook R, Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Biol Chem, 126: 111-126, 1994.
Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasrs. J Invest Dermatol, 124: 886-892, 2005.
Moore BB, Kolodsick JE, Thanninckal VJ, Cooke K, Moore TA, Hogaboam C, Wilke CA, Toews GB. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol, 166: 675-684, 2005.
Oka N, Yamamoto M, Schwencke C, Kawabe J-I, Ebina T, Ohno S, Couet J, Lisanti MP, Ishikawa Y. Caveolin interaction with protein kinase C. J Biol Chem, 272:33416-33421, 1997.
Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing ‘pre-assembled signaling complexes’ at the plasma membrane. J Biol Chem, 273:5419-5422, 1998.
Pannu J, Nakerakanti S, Smith E, Dijke P, and Trojanowska M. Transforming Growth Factor-beta receptor type I-dependent fibrogenic gene programls mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem, 282; 10405-10413, 2007.
Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest, 114: 438-446, 2004.
Quan TE, Cowper SE, Bucala R. The role of the circulating fibrocytes in fibrosis. Curr Rheumatol Rep, 8: 145-150, 2006.
Razani B, Rubin CS, Lisanti MP. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalitic subutit of protein kinase A. J Biol Chem, 274:26353-26360, 1999.
Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russel, RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem, 276:38121-38138, 2001.
Razani B, Woodman S, Lisanti M. Caveolae: from cell biology to animal physiology. Pharmacol Rev, 54:431-467, 2002.
Rybin VO, Xu X, Steinberg SF. Activated protein kinase C isoforms target to cardiomyocyte caviolae: stimulation of local protein phosphorylation. Circ Res, 84: 980-988, 1999.
Scherer PE, Tang Z., Chun M, Sargiacomo M, Lodish HF, Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem , 270:16395-16401, 1995.
Sedding DG, Hermsen J, Seay U, Eickelberg O, Kummer W, Schwencke C, Strasser RH, Tillmanns H, and Braun-Dullaeus RC. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res 96; 635-642, 2005.
Shaul P and Anderson R. Role of plasmalemmal caveolae in signal transduction. AJP Lung Cell Mol Phys, 275:L843-L851, 1998.
Shi-wen X, Chen Y, Denton CP,Eastwood M, Renzoni EA, Bou-Gharios G, Pearson JD, Dashwood M, duBois RM, Black CM, Leask A, Abraham DJ. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/PI3 kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. MBC,15: 2707-2719, 2004.
Shi-Wen X, Rodriguez-Pascual F, Lamas S, Holmes A, Howat S, Pearson JP, Dashwood MR, du Bois RM, Denton CP, Black CM, Abraham DJ, and Leask A. Constitutive ALK5-independent c-Jun N-Terminal Kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol Cel Biol, 26; 5518-5527, 2006.
Song KS, Li S, Okamoto T, Guilliam LA, Sargiacomo M, Lisanti MP. Co-p
Hoffman Stanley
Tourkina Elena
Ballard Spahr LLP
Chandra Gyan
Medical University of South Carolina
LandOfFree
Method of treating fibrosis in a subject in need thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating fibrosis in a subject in need thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating fibrosis in a subject in need thereof... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4301942